The class I and class II major histocompatibility complex (MHC) antigens are polymorphic cell-surface glycoproteins that present antigenic peptides to T lymphocytes in the generation of immune responses. While much is known about the recognition and processing of antigens, the nature of T-cell recognition sites on MHC molecules is poorly understood. Both structural and functional studies have suggested that the two major a-helical regions of the class I MHC molecule not only define the site for binding of antigenic peptide but also provide potential sites for interaction of the MHC molecule with the T-cell receptor. A peptide derived from one of these regions on the H-2Kb molecule, peptide Kb163-174, was previously shown to specifically inhibit the stimulation of an alloreactive T-cell hybridoma. To further investigate the role of this region in the recognition of H-2Kb, the effects of peptide Kb163-174 on allospecific T-cell lines and clones were studied. When peptide Kb163-174 was cocultured with either an H-2Kbmlo anti-H-2Kb cytotoxic T-lymphocyte (CTL) clone or a CTL line, this peptide inhibited lysis of H-2Kb targets. Pretreatment experiments showed that the blockade was due to interaction of the peptide with the effector T cells. Surprisingly, peptide Kb163-174 also inhibited lysis of H-2Kb targets by H-2Kbm., H-2Kbm3_, H-2Kbm6_, and H-2Kbm -anti-H-2Kb CTLs. These CTLs, which identify multiple antigenic sites on H-2Kb in the a, and a2 domains, are not directed against amino acid residues 163-174 of H-2Kb. In addition, peptide Kb163 174 specifically blocked lysis of only H-2Kb and not H-2Ld targets by a single bulk CTL culture that was alloreactive on both H-2Kb and H-2Ld. These results indicate that peptide Kb163-174 interferes with T-cell receptor engagement of a contact site on the H-2Kb molecule. Thus, amino acid residues 163-174 define a site used by many alloreactive T cells to engage the H-2Kb molecule.
The major histocompatibility complex (MHC) antigens are polymorphic cell-surface glycoproteins with critical roles in the generation of immune responses (reviewed in refs. 1 and 2). Class I MHC molecules, originally described as the classical transplantation antigens involved in allograft tissue rejection (3) , and class II MHC molecules, the products of the classical immune response (Ir) genes, have similar functions in the presentation of antigens to cytotoxic (CD8+) and helper (CD4+) T lymphocytes, respectively (4) . Class I molecules seem to be primarily involved in the display of endogenously synthesized viral, tumor, or minor antigens, while class II molecules are capable of presenting processed or denatured forms of soluble proteins taken up from the extracellular environment. Studies on the basis of the ability of MHC proteins to present foreign antigen have demonstrated the functional and biochemical association of antigenic peptide fragments with MHC class I and II molecules (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) .
While much is known about the recognition and processing of antigens, the nature of T-cell recognition sites on MHC molecules in both alloresponses and MHC restricted responses is poorly understood. Recent work, showing a role of an undetermined cell-specific self antigen in the generation of anti-I-E alloresponses (15) , supports the hypothesis that allogeneic responses involve the recognition of an undetermined spectrum of resident self antigens in the MHC molecule (16) . The fraction of alloresponses dependent on unknown self peptide antigens as compared to the fraction of the alloresponse due to recognition of "naked" MHC remains an open question.
Clearly, MHC-restricted T cells recognize determinants from both foreign antigens and MHC molecules. Both structural and functional studies implicate the two major membrane distal protein domains, a1 and a2, in the interaction of MHC proteins with both antigenic peptides and T-cell receptors (17) (18) (19) (20) (21) . The recent x-ray crystallographic solution of the human HLA-A2 class I molecule suggests that the a-helical regions of the a1 and a2 domains are potential binding regions for T-cell receptors (22, 23) . Studies of alloreactive human anti-HLA-A2 cytotoxic T-lymphocyte (CTL) lines that were inhibited by peptides from different regions in the class I molecule have identified two regions in the human HLA-A2 molecule (amino acid residues 98-113 and 56-69), which are potential T-cell contact sites (24, 25) . More recently, studies with in vitro derived MHC mutants also suggest that multiple sites from both helical regions simultaneously contribute to the binding of the H-2Kb MHC class I molecule to T-cell receptors (26) .
Previously, a peptide derived from an exposed a-helical region of H-2Kb, peptide 163-174, was shown to inhibit stimulation of an alloreactive T-cell hybridoma (27 (Fig. 1C) . In all cases, cytolysis was assessed in a standard 4-to 6-hr assay as described (29) . Percent specific lysis was calculated according to the following formula: % specific lysis = 
One lytic unit was defined as the number of effector cells necessary to lyse 30% of 105 target cells.
Cell Lines and Culture Conditions. L cells were maintained by 1:10 passage twice weekly and cultured in DME-10 [Dulbecco's modified essential medium (DMEM; M.A. Bioproducts)] supplemented with 2 mM glutamine, nonessential amino acids, 10 mM Hepes, 50 ,ug of gentamicin per ml, 50 ,uM 2-mercaptoethanol, and 10% fetal calf serum. L-cell transformants have been described (27) .
Peptides. All peptides were synthesized by solid-phase methodology with an automated peptide synthesizer. Standard t-butoxycarbonyl-chemistries were used and the peptides were cleaved from the solid support by liquid HF. The cleaved peptides were purified by gel-filtration chromatography on a P-2 column (Bio-Rad). The purified peptides were analyzed by amino acid composition and reverse-phase HPLC. The inhibitory activity of peptide Kb163-174 was seen with different lots of synthesized peptide as well as with HPLC purified peptide. A peptide concentration of 100 jig/ml represents a final molar concentration of 63 ,uM for Kb163-174 and 56 ,uM for Kb37-50. Peptides were prepared as stock solutions of 10 mg/ml in phosphate-buffered saline and stored at -20°C. and 174 in the allospecific recognition of H-2Kb was analyzed by examining allospecific T-cell responses to H-2Kb in the presence of peptide Kb163-174. First, we examined lysis by an allospecific H-2Kbm'o anti-H-2Kb CTL clone, which is directed against amino acid residues 163-174, the region of the bmlO mutation. Lysis of H-2Kb target cells by this allospecific H-2Kbm'o anti-H-2Kb CTL clone was blocked by peptide (Fig. 1A) . In contrast, peptide Kb163-174 did not inhibit lysis of H-2Ld target cells by an allospecific anti-H-2Ld CTL clone (Fig. 1B) . Thus, blockade by peptide Kb163-174 is not the result of nonspecific inhibition of CTLs. Peptide Kb163-174 half-maximally inhibited CTL lysis by clone 37 at a concentration of 25 ,ug/ml (15.7 IxM). A control peptide representing a different region of the H-2Kb molecule, between amino acid residues 37 and 50, had no effect on lysis by either of the CTL clones. In addition, lysis of H-2Kb targets by an H-2Kbmlo anti-H-2Kb CTL line was also blocked by peptide Kb163-174 (Fig. 1C) (Fig. 2F) .
RESULTS
Although pretreatment experiments showed that inhibitory activity of the peptide Kb163-174 was at the level of the effector T cells, it was possible that this peptide was interacting with a T-cell membrane molecule unrelated to the clonotypic T-cell receptor. Such an interaction could sensitize the effector cells to be targets of veto cell activity (30 H-2Kb and anti-H-2Ld CTL activity. To accomplish this, CTLs that were generated from a single B1O.BR anti-CB6F1 (H-2k anti-H-2dxb) culture were tested for the ability to lyse and not H-2Ld target cells by these CTLs generated from a single response culture (Fig. 3) . Thus, blockade by peptide Kb163-174 was related to the receptor specificity of the individual CTL and was not due to a veto mechanism of inhibition by the peptide. Additional experiments were performed to further evaluate the possibility of an interaction between peptide Kb163-174 and the class I molecules on the effector CTL. We considered that the inhibition of lysis by peptide Kb163-174 was sec- hr at 370C and washed once prior to usage as target cells. Clone 37 cells were used at an E/T ratio of 10: 1 in the assay. At this E/T ratio, 22% specific lysis of 1-3 cells (H-2Kb transfected L cells) was observed. Percent specific lysis was calculated as described. The values shown are means for triplicate wells.
ondary to binding and alteration of the MHC product on the effector T cells causing them to serve as cold target inhibitors of anti-H-2Kb CTLs. Were this the case, peptide Kb163-174 should sensitize target cells expressing H-2Kbm1o or H-2k haplotype MHC molecule for lysis by anti-H-2Kb CTLs. However, prepulsing of both untransfected (H-2k) and H2Kbmlo-transfected L cells with peptide Kb163-174 failed to sensitize either target for lysis by the anti-H-2Kb CTL clone (Table 1 ). In addition, anti-H-2Kbmlo-specific antibody (31) was used to examine the potential interaction of peptide Kb163-174 with the H-2Kbm10 class I molecule expressed on the effector CTL clone 37. While monoclonal anti-H-2Kbmlo-specific antibody inhibited B10 anti-H-2Kbm1 CTLs, it failed to reverse the inhibition of lysis by peptide Kb163-174 (Table  2) . Thus, we were unable to show any functional association between the class I molecules expressed on effector CTLs and peptide Kb163-174.
DISCUSSION
The experiments presented in this paper demonstrate that H-2KbmlO anti-H-2Kb CTL clone, line, or bulk cultures can be blocked by a peptide whose sequence is identical to H-2Kb between amino acids 163 and 174, the region of the H-2Kbmlo mutation. Pretreatment experiments indicate that blockade is at the level of the effector T cell. Unexpectedly, anti-H-2Kb CTL cultures derived from H-2Kbm1, H-2Kbm3, H-2Kbm6, and H-2Kbm8, which are identical to H-2Kb between residues 163 and 174, were also inhibited by peptide Kb163-174. Thus, blockade by peptide Kb163-174 was independent of the region between amino acids 163 and 174 being a foreign site. The simplest interpretation of these results is that peptide Kb163-174 defines a necessary region in H-2Kb required for contact by clonotypic T-cell receptors. It is important to evaluate possible mechanisms of inhibition by peptide Kb163-174. The (1989) dependent responses, such as the allospecific anti-H-2Ld CTL clone (Fig. 1) and primary bulk cultures (Fig. 3) . Thus, we think the most likely interpretation is that peptide Kb163-174 inhibits lysis by interaction with the clonotypic T-cell receptor.
The present study supports and extends the concept that specific regions of the MHC molecule are involved in allorecognition. Blockade of CTL-mediated lysis in several different H-2Kb mutant anti-H-2Kb heterogeneous bulk CTLs by peptide Kb163-174 indicates that this region is critically involved in the interaction of H-2Kb with many different T-cell receptors. Thus, inhibition of lysis was independent of the site between amino acids 163 and 174 being an allodeterminant. In contrast, two T-cell binding regions, one between amino acid residues 98 and 113 and a second between residues 56 and 69, which were identified on human HLA-A2, are dependent on the site being an allodeterminant and reflect the specificity of individual T-cell clones (24, 25) . Other experiments with in vitro derived mutants in H-2Kb also indicate that allogeneic T cells simultaneously contact several different regions on both a, and a2 helices of the H-2Kb molecule (26) . If topographically T-cell receptors actually contact multiple exposed regions on MHC molecules, then the sum of these multiple MHC-T-cell receptor interactions is functionally the interaction of the MHC histotope with the T-cell receptor. Our experiments directly assess the interaction between one ofthese necessary contact sites on a MHC molecule and T-cell receptors.
Insight into the importance of the region of H-2Kb spanned by peptide 163-174 can be gained from structural models of H-2Kb based on the crystallographic structure of human HLA-A2 (22, 23) . Amino acid residues 163-174 identify a stretch of a-helix in the a2 domain with several residues exposed to solvent and presumably available for interaction with T-cell receptors (Fig. 4) . A comparison of murine classical class I amino acid sequences in this region indicates the conservation of residues 164-168 throughout all these proteins. H-2Kbmo has substitutions at positions 165 and 167 characteristic of Qa-region molecules (18, 27, 33) . Despite the primary amino acid sequence similarities between the various class I MHC molecules, anti-H-2Ld CTLs were not blocked by the peptide Kb163-174. If this region ofthe MHC molecule is utilized by allogeneic anti-H-2Ld T-cell receptors, this result implies that residues 163 and/or 169 are critical to the specificity of the T-cell-MHC interaction. In addition, the failure of the peptide to inhibit the H-2b anti-H-2k CTL suggests that the substitutions at positions 173 and 174 are also important. Either these residues may serve as direct T-cell contact sites, or elimination of the basic residue at position 173 may influence the stability of this a-helical region (34) . While the precise role of the different amino acid residues in this region is still unknown, our data indicate that the exposed surface of the classical class I MHC molecule H-2Kb between amino acid residues 163 and 174 has a critical role in the interaction of the H-2Kb MHC molecule with T-cell receptors.
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